Partnering

Initial situation

• Biotechnology company with a patent protected first-in-class immunomodulatory drug in pipeline  –  new mode of action
• Phase I successfully complemented
• Active ingredient can be developed for different indications with indication-specific, galenic dosage forms
• Company is looking for mid-size, indication-specific co-development partners to finance prove of concept studies
• Phase III and launch will be done subsequent in cooperation with a global/regional partner and the current co-development partner

Tasks for SANEMUS

• Identification of potential, indication-specific co-development partners
• Contacting potential partners
• Initiating licensing process and participation in contract negotiations